Chelated lead in relation to lead in bone and ALAD genotype

Environmental Research

Volumn 80, Issue 4, 1999, Pages 389-398

  Gerhardsson, Lars ^a   Börjesson, Jimmy ^a   Mattsson, Sören ^a   Schütz, Andrejs ^a   Skerfving, Staffan ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood; Bone; Chelation; DMSA; Exposure index; Lead; Smelter; Urine

Indexed keywords

LEAD; SUCCIMER;

ARTICLE; BONE BIOPSY; BONE LEVEL; CHELATION; CONTAMINATION; DRUG ACCUMULATION; GASTROINTESTINAL ABSORPTION; GENOTYPE; HUMAN; HUMAN CELL; LEAD POISONING; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; SMELTER; TRABECULAR BONE;

EID: 0345280741     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1006/enrs.1998.3936     Document Type: Article

References (35)

1. Ahlgren L., Lidén K., Mattsson S., Tejning S. X-ray fluorescence analysis of lead in human skeleton in vivo. Scand. J. Work Environ. Health. 2:1976;82-86.
2. Altman D. G. Practical Statistics for Medical Research. 1991;Chapman & Hall, London.
3. Aposhian H. V., Aposhian M. M. Meso-2,3-dimercaptosuccinic acid: Chemical, pharmacological and toxicological properties of an orally effective metal chelating agent. Annu. Rev. Pharmacol. Toxicol. 30:1990;279-306.
4. Araki S., Ushio K. Assessment of the body burden of chelatable lead: A model and its application to lead workers. Br. J. Ind. Med. 39:1982;157-160.
5. Barry P. S. A comparison of concentrations of lead in human tissues. Br. J. Ind. Med. 32:1975;119-139.
6. Bergdahl I. A, Desnick R. J., Gerhardsson L., Schütz A., Skerfving S., Wetmur R. Delta-aminolevulinic acid dehydratase polymorphism: Influence on lead levels and kidney function in humans. Arch. Environ. Health. 52:1997;91-96.
7. Börjesson J., Gerhardsson L., Schütz A., Mattsson S., Skerfving S., Österberg K. In vivo measurements of lead in fingerbone in active and retired lead smelters. Int. Arch. Occup. Environ. Health. 69:1997;97-105.
8. Chisolm J. J. Mobilization of lead by calcium disodium edetate. Am. J. Dis. Child. 141:1987;1256-1257.
9. Christoffersson J.-O., Ahlgren L., Mattsson S., Schütz A., Skerfving S. Decrease of skeletal lead levels in man after end of occupational exposure. Arch. Environ. Health. 42:1986;312-318.
10. Christoffersson J.-O., Schütz A., Ahlgren L., Haeger-Aronsen B., Mattsson S., Skerfving S. Lead in fingerbone analysed in vivo in active and retired lead workers. Am. J. Ind. Med. 6:1984;447-457.
11. Cory-Slechta D. A. Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy. J. Pharmacol. Exp. Ther. 246:1988;84-91.
12. Cory-Slechta D. A., Weiss B., Cox C. Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J. Pharmacol. Exp. Ther. 243:1987;804-813.
13. Cramér K., Selander S. Studies in lead poisoning: Comparison between different laboratory tests. Br. J. Ind. Med. 22:1965;311-314.
14. Gerhardsson L., Hagmar L., Rylander L., Skerfving S. Mortality and cancer incidence among secondary lead smelter workers. Occup. Environ. Med. 52:1995;667-672.
15. Gibson K. D., Neuberger A., Scott J. J. The purification and properties ofδ Biochem. J. 61:1955;618-629.
16. Greenberg A., Parkinson D. K., Fetterolf D. E., Puschett J. B., Ellis K. J., Wielopolski L., Vaswani A. N., Cohn S. J., Landrigan P. J. Effects of elevated lead and cadmium burdens on renal function and calcium metabolism. Arch. Environ. Health. 41:1986;69-76.
17. Kapoor S. C., Wielopolski L., Graziano J. H., Lolacono N. J. Influence of 2,3-dimercaptosuccinic acid on gastrointestinal lead absorption and whole-body lead retention. Toxicol. Appl. Pharmacol. 97:1989;525-529.
18. Lee B.-K., Schwartz B. S., Stewart W., Ahn K.-D. Provocative chelation with DMSA and EDTA: Evidence for differential access to lead storage sites. Occup. Environ. Med. 52:1995;13-19.
19. 2. J. Pediatr. 104:1984;337-341.
20. Nilsson U., Attewell R., Christoffersson J.-O., Schütz A., Ahlgren L., Skerfving S., Mattsson S. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol. Toxicol. 68:1991;477-484.
21. Ohlsson W. T. Detection of exposure to lead by mobilization test with peroral penicillamine. Occup. Health. Rev. 15:1963;14-18.
22. Schwartz B. S., Lee B.-K., Stewart W., Ahn K.-D., Springer K., Kelsey K. Associations ofδ Am. J. Epidemiol. 142:1995;738-745.
23. Schwartz B. S., Lee B.-K., Stewart W., Sithisarankul P., Strickland P. T., Ahn K.-D., Kelsey K. δ Occup. Environ. Med. 54:1997;241-246.
24. Schütz A., Skerfving S., Christoffersson J.-O., Tell I. Chelatable lead versus lead in human trabecular and compact bone. Sci. Total Environ. 61:1987a;201-209.
25. Schütz A., Skerfving S., Christoffersson J.-O., Ahlgren L., Mattsson S. Lead in vertebral bone biopsies from active and retired lead workers. Arch. Environ. Health. 42:1987b;340-346.
26. Schütz A., Bergdahl I. A., Ekholm A., Skerfving S. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup. Environ. Med. 53:1996;736-740.
27. Sithisarankul P, Schwartz B., Lee B.-K., Kelsey K. T., Strickland P. T. Aminolevulinic acid dehydratase genotype mediates plasma levels of the neurotoxin 5-aminolevulinic acid in lead-exposed workers. Am. J. Ind. Med. 32:1997;15-20.
28. Skerfving S. Inorganic lead. Criteria Documents from the Nordic Expert Group. 1:1993;Nordic Council of Ministers. p. 125-238.
29. Skerfving S., Nilsson U., Schütz A., Gerhardsson L. Biological monitoring of inorganic lead. Scand. J. Work. Environ. Health. 19:1993;59-64.
30. Smith C. M., Wang X., Hu H., Kelsey K. T. A polymorphism in theδ Environ. Health Perspect. 103:1995;248-253.
31. Somervaille L. J., Nilsson U., Chettle D. R., Tell I., Scott M. C., Schütz A., Mattsson S., Skerfving S. In vivo measurements of bone lead - A comparison of two X-ray fluorescence techniques used at three different bone sites. Phys. Med. Biol. 34:1989;1833-1845.
32. Tell I., Somervaille L. J., Nilsson U., Bensryd I., Schütz A., Chettle D. R., Scott M. C., Skerfving S. Chelated lead and bone lead. Scand. J. Work Environ. Health. 18:1992;113-119.
33. 22. Am. J. Hum. Genet. 49:1991a;757-763.
34. Wetmur J. G., Lehnert G., Desnick R. J. Theδ Environ. Res. 56:1991b;109-119.
35. Wielopolski L., Ellis K. J., Vaswani A. N., Cohn S. H., Greenberg A., Pushett J. B. In vivo bone lead measurements: A rapid monitoring method for cumulative lead exposure. Am. J. Ind. Med. 9:1986;221-226.